Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples